Clinical Trial Update: Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating nelfinavir with radiation, cisplatin, and etoposide in stage III non-small cell lung cancer unsuitable for surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Nelfinavir (nelfinavir)
• Radiation therapy

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-04-24